Creative Biolabs Expands Complement Assay Services to Support Drug Discovery and Preclinical Research
Creative Biolabs expands its complement assay portfolio to include C3b deposition, haemolysis inhibition, and individual complement component activity testing in support of complement-focused drug discovery and preclinical research.






